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In predisposed subjects with migraine or tension-type
headache increasing intake of acute medications is asso-
ciated with a progressive clinical worsening. When the
days of symptomatic drug use reach a given threshold (10
or 15 days/month, depending on the classes of drugs,
ICHD-III) and the headache has become chronic for at
least three months, a causal relationship is deemed to exist
between the medication overuse and the clinical worsen-
ing, and the headache is termed medication-overuse head-
ache (MOH). MOH affects nearly 2% of the general
population. It represents a highly disabling condition that
impacts considerably on the quality of life of sufferers and
on the society in general because of high levels of disability
and use of healthcare resources.
MOH is treatable: withdrawal from overused drugs leads
to a clinically significant improvement in the majority of
patients. Even more so, when it is performed within an
integrated approach aimed at targeting frequent associated
features/conditions (i.e., muscle tenderness and contrac-
tures, psychological disturbances, increased stress levels)
and in the most appropriate clinical settings (i.e., outpati-
ents clinics for simple MOH, hospitalization for complex
MOH). Some Authors also report improvement with pro-
phylactic medication (topiramate, botulinum toxin) alone.
Increasing amount of evidence suggests that the clinical
process leading to MOH is paralleled by the establishment
of chronic sensitization, which is partly reversed by with-
drawal of overused drugs. In addition, several experimental
reports confirm that frequent use of analgesics or triptans
facilitates nociception, probably via the overexpression of
CGRP and neuronal NOS in the trigeminal ganglion.
Clinical practice and analysis of the literature suggest
that the beneficial effect of drug withdrawal tends to be
more marked and abrupt as compared to the reported
slower reduction of headache days when prophylactic
medication alone is used. Direct comparison trials are
however lacking.
A major issue to be addressed is the high risk of relapse
into overuse and pain chronicity following improvement.
A good wealth of literature findings has allowed precise
quantification of the rate of relapse into overuse and pain
chronicity following drug withdrawal (alone or in combi-
nation with prophylactic mediation), while data are miss-
ing as regards relapse rates following prophylactic
treatment alone for MOH.
Taking all these observations into consideration, and
awaiting for the necessary evidence from comparative
trials, presently the optimal approach to MOH seems to
be provided by a multistep process that possibly includes
all of the following procedures:
1. Patient’s education regarding the need to stop
overuse;
2. Withdrawal from overused drugs;
3. Management of comorbid conditions;
4. Optimization of symptomatic medications;
5. Personalization of prophylactic medication.
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